1271 – 1280 of 1301
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
(
- Contribution to journal › Article
-
Mark
Blood pressure and drug treatment in clinically diagnosed Lewy body dementia and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Nya rön om Alzheimers sjukdom: Gott hopp om att biokemiska markörer kan skärpa diagnostiken
(
- Contribution to journal › Article
-
Mark
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
(
- Contribution to journal › Article
-
Mark
Expression of Meis and Pbx genes and their protein products in the developing telencephalon : Implications for regional differentiation
(
- Contribution to journal › Article
- 1999
-
Mark
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
(
- Contribution to journal › Article
- 1998
-
Mark
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease
(
- Contribution to journal › Article
- 1997
-
Mark
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
(
- Contribution to journal › Article
-
Mark
Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia
(
- Contribution to journal › Article